Screener
Mesa Laboratories MLAB Calibration Solutions — Cost Of Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Mesa Laboratories in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Mesa Laboratories’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026808
| Three months ended June 30, 2026 | Sterilization and Disinfection Control | Biopharmaceutical Development | Calibration Solutions | Clinical Genomics | Total |
|---|---|---|---|---|---|
| Depreciation in cost of revenue | 437 | 78 | 111 | 119 | 745 |
| Amortization in cost of revenue | 121 | 379 | - | 191 | 691 |
| Other cost of revenue (b) | 6,788 | 4,020 | 5,143 | 3,739 | 19,690 |
| Total segment cost of revenue | 7,346 | 4,477 | 5,254 | 4,049 | 21,126 |
| Gross Profit (c) | $17,159 | $7,582 | $8,031 | $6,240 | $39,012 |
| Reconciling items: | |||||
| Operating expense | $31,981 | ||||
| Operating income | 7,031 |
Document
FAQ
- What is Mesa Laboratories's calibration solutions — cost of revenue?
- Mesa Laboratories (MLAB) reported calibration solutions — cost of revenue of $5.25M in Q2 2026.
- How has Mesa Laboratories's calibration solutions — cost of revenue changed year-over-year?
- Mesa Laboratories's calibration solutions — cost of revenue decreased by 1.0% year-over-year, from $5.31M to $5.25M.
- What does calibration solutions — cost of revenue mean?
- This metric aggregates all direct costs incurred to produce and deliver the products and services sold by the Calibration Solutions segment. It is a fundamental measure for evaluating the segment's direct operational efficiency and cost control management.
Ask your AI about Mesa Laboratories's calibration solutions — cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude